Donnelly Brian J 4

What Happened

• Brian J. Donnelly, Chief Commercial Officer of Myriad Genetics (MYGN), had 55,975 shares of common stock withheld by the company to satisfy tax withholding related to vested restricted stock units. The withholding was recorded at $4.80 per share for a total value of $268,680. This is a tax-withholding disposition (transaction code F), not an open-market sale or new purchase.

Key Details

• Transaction date: 2026-05-01; Filing date: 2026-05-04 (Form 4 accession 0002065630-26-000004).
• Shares withheld/disposed: 55,975 at $4.80 per share; total value $268,680.
• Shares owned after transaction: not specified in the provided filing details.
• Footnote: F1 — shares were withheld by the issuer to satisfy tax withholding obligations tied to the vesting of previously granted RSUs; the number withheld was based on the closing price on May 1, 2026.
• Transaction type: F = tax withholding (routine administrative disposition).

Context

• This action is a routine tax-withholding event tied to RSU vesting. It reflects the company withholding shares to cover tax obligations rather than the insider selling shares on the open market — such withholdings are common and not a direct signal of insider sentiment.